Document
IPR2016-01370, No. 2045-133 Exhibit - Michaud, Direct Medical Costs and Their Predictors in Patients with Rheumatoid Arthritis (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2045-133 Exhibit - Michaud, Direct Medical Costs and Their Predictors in Patients with Rheumatoid Arthritis (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2016-01370, No. 2017-65 Exhibit - Bingham, Parenteral methotrexate should be given before biological therapy (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2017-65 Exhibit - Bingham, Parenteral methotrexate should be given before biological therapy (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2016-01370, No. 2090-122 Exhibit - Curtis (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2090-122 Exhibit - Curtis (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2016-01370, No. 2020-70 Exhibit - 2007 CDC Guidelines for Isolation Precautions Preventing Transmission of Infectious Agents in Healthcare Settings (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2020-70 Exhibit - 2007 CDC Guidelines for Isolation Precautions Preventing Transmission of Infectious Agents in Healthcare Settings (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2016-01370, No. 1014-14 Exhibit - Ex 1014 Pincus (P.T.A.B. Jul. 20, 2016)
Cite Document
IPR2016-01370, No. 1014-14 Exhibit - Ex 1014 Pincus (P.T.A.B. Jul. 20, 2016)
+ More Snippets
Document
IPR2016-01370, No. 1022-37 Exhibit - Ex 1022 PDR for Wyeth (P.T.A.B. Jul. 20, 2016)
Cite Document
IPR2016-01370, No. 1022-37 Exhibit - Ex 1022 PDR for Wyeth (P.T.A.B. Jul. 20, 2016)
+ More Snippets
Document
IPR2016-01370, No. 1003-3 Exhibit - Ex 1003 US6544504 (P.T.A.B. Jul. 20, 2016)
Cite Document
IPR2016-01370, No. 1003-3 Exhibit - Ex 1003 US6544504 (P.T.A.B. Jul. 20, 2016)
+ More Snippets
Document
IPR2016-01370, No. 1045-153 Exhibit - Notice of Abandonment of Application 14635,542 (P.T.A.B. Sep. 18, 2017)
Cite Document
IPR2016-01370, No. 1045-153 Exhibit - Notice of Abandonment of Application 14635,542 (P.T.A.B. Sep. 18, 2017)
+ More Snippets
Document
IPR2016-01370, No. 2071-92 Exhibit - FDA Summary Review Otrexup (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2071-92 Exhibit - FDA Summary Review Otrexup (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2016-01370, No. 2039-119 Exhibit - Gowdie, Review of Disease Modifying Anti Rheumatic Drugs in Paediatric Rheumatic Disease (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2039-119 Exhibit - Gowdie, Review of Disease Modifying Anti Rheumatic Drugs in Paediatric Rheumatic Disease (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2016-01370, No. 2064-81 Exhibit - Antares My View of How Otrexup and Medacs New Product Rasuvo May Compete (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2064-81 Exhibit - Antares My View of How Otrexup and Medacs New Product Rasuvo May Compete (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2016-01370, No. 2063-79 Exhibit - Antares Thoughts on the Upcoming Otrexup Launch (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2063-79 Exhibit - Antares Thoughts on the Upcoming Otrexup Launch (P.T.A.B. Jun. 9, 2017)
+ More Snippets
Document
IPR2016-01370, No. 2003-51 Exhibit - Balis, et al, Pharmacokinetics of Subcutaneous Methotrexate (P.T.A.B. Nov. 10, 2016)
Cite Document
IPR2016-01370, No. 2003-51 Exhibit - Balis, et al, Pharmacokinetics of Subcutaneous Methotrexate (P.T.A.B. Nov. 10, 2016)
+ More Snippets
Document
IPR2016-01370, No. 1038-146 Exhibit - Declaration of Kayvan Noroozi (P.T.A.B. Aug. 18, 2017)
Cite Document
IPR2016-01370, No. 1038-146 Exhibit - Declaration of Kayvan Noroozi (P.T.A.B. Aug. 18, 2017)
+ More Snippets
Document
IPR2016-01370, No. 2091-123 Exhibit - Striesow (P.T.A.B. Jun. 9, 2017)
Cite Document
IPR2016-01370, No. 2091-123 Exhibit - Striesow (P.T.A.B. Jun. 9, 2017)
+ More Snippets